CGN:LYX
$0.02
-
0.00%

Cognetivity Neurosciences Ltd - Ordinary Shares
News & Events

Last updated: May 9, 2025, 5:33 AM ET

  1. Canadian Investment Regulatory Organization Trading Halt - CGN

    Canada Newswire JUN 6, 2024 8:27 AM EDT
    Canadian Investment Regulatory Organization Trading Halt - CGN Canada NewsWire ...
    READ ARTICLE
  2. CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service

    Newsfile OCT 24, 2023 9:00 AM EDT
    Latest Peer-Reviewed Study Published in Frontiers in Public Health Highlights Cost-Efficiency and...
    READ ARTICLE
  3. Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA

    Newsfile OCT 11, 2023 9:00 AM EDT
    Collaboration With Highly Rated Healthcare Provider Opens US Healthcare Market for Brain Health f...
    READ ARTICLE
  4. Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s

    Newsfile OCT 3, 2023 9:24 AM EDT
    Program Designed to Identify Age-Related Brain Health Issues at an Early Stage, Allowing Effectiv...
    READ ARTICLE
  5. Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology

    Newsfile SEP 21, 2023 9:15 AM EDT
    New Approach to Measuring Impact of Counselling to Deliver Next Generation Care to Mental Health ...
    READ ARTICLE
  6. Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award

    Newsfile SEP 13, 2023 9:00 AM EDT
    CognICA Chosen as Winner of Best AI Product in Healthcare Award at CogX Festival Vancouver, Brit...
    READ ARTICLE
  7. Cognetivity Neurosciences' AI Powered CognICA Platform Shortlisted for Major Industry Award

    Newsfile SEP 5, 2023 8:45 AM EDT
    CognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX Festival Vancouve...
    READ ARTICLE
  8. Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer's Disease

    Newsfile AUG 30, 2023 8:45 AM EDT
    Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading N...
    READ ARTICLE
  9. Cognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada

    Newsfile AUG 2, 2023 8:48 AM EDT
    Approval opens up a new major market for CognICA, providing a solution to the urgent requirement ...
    READ ARTICLE
  10. New Disease Modifying Drug for Alzheimer's Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring

    Newsfile JUL 7, 2023 9:00 AM EDT
    Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetiv...
    READ ARTICLE

Upcoming Events

Get notified of Cognetivity Neurosciences Ltd - Ordinary Shares’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available